Access catheter Dualpro™ IVUS+NIRS

cardiaccoronary

The only dual-modality intravascular imaging catheter that helps you identify lipid-core plaques that is at an increased risk of major adverse cardiac events. The only intravascular imaging modality proven to identify LCP and risk of major adverse cardiac events Dualpro™ IVUS+NIRS is the only dual-modality intravascular imaging catheter equipped with Near-Infrared Spectroscopy (NIRS) delivering intel on plaque composition and giving you the power to make highly informed decisions right in the Cath lab. Now you can easily identify unstable lipid core plaque (LCP) – a well-documented culprit in heart disease associated with 95% of STEMIs and an increased risk of peri-procedural complications.1,2 With the power of Dualpro IVUS+NIRS, you can identify patients and plaque at a higher risk of MACE and readily distinguish between stable plaque and vulnerable LCP. The value of NIRS in detecting risk of MACE Multiple studies have demonstrated that assessment of the coronary artery with the Makoto IVUS+NIRS Intravascular Imaging System is unmatched in its ability to identify the risk of MACE. The results of the landmark LP study provided clinical evidence that intravascular NIRS imaging can accurately identify both vulnerable patients and vulnerable plaques that are at significantly higher risk for subsequent NC-MACE during a 24-month period.